Alpha Cognition Q3 net loss swings to $7.62 million from year-earlier profit
ACOG•Alpha Cognition reported a third-quarter 2026 net loss of $7.62 million, compared with a profit a year earlier, as net product revenue more than tripled to $7.8 million. It reiterated 2026 R&D and SG&A expense guidance of $50 million–$54 million and its goal of operating profitability in 2027.
1. Revenue and prescriptions
Net product revenue more than tripled year-over-year to $7.8 million, driven by increased sales volume. Bottles dispensed climbed 31% quarter-over-quarter to 10,896, while cumulative prescribers reached 2,410, exceeding the original full-year goal.
2. Guidance maintained
Management reiterated 2026 R&D and SG&A expense guidance of $50 million–$54 million and maintained its goal of operating profitability in 2027.
